DEBIOS Diagnostics

DEBIOS Diagnostics, a spin-off from the Germans Trias i Pujol Research Institute, specializes in the early diagnosis and monitoring of genitourinary diseases, including Chronic Kidney Disease and kidney transplant failure. The company collaborates with international clinical key opinion leaders and institutions to discover novel biomarkers, advancing the field of non-invasive diagnostics. DEBIOS Diagnostics focuses on providing personalized healthcare solutions that enable early detection and individualized treatment plans. The business model revolves around offering non-invasive diagnostic and prognostic tools, reshaping the future of genitourinary disease diagnostics in partnership with the clinician community. The company primarily serves clinicians and healthcare institutions, operating in the global healthcare market. Revenue is generated through the development and sale of diagnostic solutions that enhance clinical decision-making and patient outcomes.

Keywords: genitourinary, diagnostics, biomarkers, non-invasive, personalized, healthcare, clinicians, chronic kidney disease, prognostics, early detection.